Improved Combination of Protease and Protease Inhibitor with Secondary Enzyme
Summary
The European Patent Office published patent EP4217368A1, granted to BASF SE, covering an improved combination of protease and protease inhibitor with secondary enzyme. The invention relates to protease-protease inhibitor compositions for industrial applications, classified under C07K, C11D, and C12N. The patent is designated across 31 European states including DE, FR, GB, IT, ES, and NL.
What changed
EPO granted patent EP4217368A1 to BASF SE for an invention relating to an improved combination of protease and protease inhibitor with secondary enzyme. The patent covers compositions and methods for industrial applications using protease-protease inhibitor combinations, with IPC classifications spanning pharmaceutical chemistry (C07K), cleaning compositions (C11D), and enzyme technology (C12N).
Pharmaceutical and chemical companies developing enzyme-based products should monitor this patent portfolio. The designated states cover major European markets, making this relevant for any entity operating in the European enzyme or cleaning product space. While patent grants do not impose compliance obligations, companies may wish to evaluate whether their R&D activities could fall within the scope of these claims.
What to do next
- Monitor for updates if developing protease-based formulations
- Review patent claims for potential licensing considerations
Archived snapshot
Apr 8, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IMPROVED COMBINATION OF PROTEASE AND PROTEASE INHIBITOR WITH SECONDARY ENZYME
Publication EP4217368A1 Kind: A1 Apr 01, 2026
Applicants
BASF SE
Inventors
JENEWEIN, Stefan, BOENEMANN, Gabriele
IPC Classifications
C07K 5/083 20060101AFI20220402BHEP C11D 3/20 20060101ALI20220402BHEP C12N 9/14 20060101ALI20220402BHEP C11D 3/32 20060101ALI20220402BHEP C11D 3/386 20060101ALI20220402BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.